Sunday, December 4, 2016

Nelson Vergel Interviews Two Leading Facial Lipoatrophy Experts


December 2, 2016


___________________________________________________________________________________ 


Watch these videos as Nelson interviews two leading experts on facial lipoatrophy reconstructive procedures to update us on the latest advances in that field. HIV lipoatrophy (the involuntary loss of subcutaneous fat) was found to be accelerated by the use of Zerit (stavudine, d4T) and AZT (zidovudine, Retrovir). HIV lipoatrophy causes facial, buttock and extremity wasting. Many patients switched away from those drugs, but their facial and body lipoatrophy has not reversed even after years of drug cessation. Even though there are two products approved by the Food and Drug Administration for facial lipoatrophy, both are temporary and costly. Access to manufacturers' patient assistance programs and insurance coverage are limited and still leave a considerable out-of-pocket expense for the patient. In these two interviews, Luis Casavantes, M.D., from Mexico and Gerald Pierone Jr., M.D. (expert at TheBody.com) from Florida discuss permanent solutions not only for the face but other body areas affected by lipoatrophy.

To ask questions of Dr. Pierone or Nelson, please visit our "Ask the Experts" section. Nelson has also created a website called FacialWasting.org for more details on all available lipoatrophy reconstruction options.

Dr. Luis Casavantes interview on facial, buttock and penile fillers:
 




Dr. Gerald Pierone Jr. interview on HIV lipodystrophy options:





JD Davids is the managing editor for TheBody.com and TheBodyPRO.com.
Follow JD on Twitter: @JDAtTheBody.

Read more articles from The Body, here.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.